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Microtubules function as molecular tracks along which motor
proteins transport a variety of cargo to discrete destinations within
the cell. The carboxyl termini of - and -tubulin can undergo
different posttranslational modifications, including polyglutamy-
lation, which is particularly abundant within the mammalian ner-
vous system. Thus, this modification could serve as a molecular
‘‘traffic sign’’ for motor proteins in neuronal cells. To investigate
whether polyglutamylated -tubulin could perform this function,
we analyzed ROSA22 mice that lack functional PGs1, a subunit of
-tubulin-selective polyglutamylase. In wild-type mice, polyglu-
tamylated -tubulin is abundant in both axonal and dendritic
neurites. ROSA22 mutants display a striking loss of polyglutamy-
lated -tubulin within neurons, including their neurites, which is
associated with decreased binding affinity of certain structural
microtubule-associated proteins and motor proteins, including
kinesins, to microtubules purified from ROSA22-mutant brain. Of
the kinesins examined, KIF1A, a subfamily of kinesin-3, was less
abundant in neurites from ROSA22 mutants in vitro and in vivo,
whereas the distribution of KIF3A (kinesin-2) and KIF5 (kinesin-1)
appeared unaltered. The density of synaptic vesicles, a cargo of
KIF1A, was decreased in synaptic terminals in the CA1 region of
hippocampus in ROSA22 mutants. Consistent with this finding,
ROSA22 mutants displayed more rapid depletion of synaptic ves-
icles than wild-type littermates after high-frequency stimulation.
These data provide evidence for a role of polyglutamylation of
-tubulin in vivo, as a molecular traffic sign for targeting of KIF1
kinesin required for continuous synaptic transmission.
kinesin  microtubules  synaptic vesicles  trafficking  tyrosination
M icrotubules have important roles in intracellular transport,cell motility, cell division, and cell morphogenesis. Neuronal
cells use this component of the cytoskeleton to distribute a wide
variety of cargo to neurite terminals that can be farther than 1 m
from the cell body. Molecular motors transport synaptic vesicle
precursors (1), neurotransmitter receptors (2, 3), and organelles
such as mitochondria (4) along the microtubule network to their
appropriate subcellular destinations, i.e., axonal terminals or den-
drites (5). A central question in biology is how themolecularmotors
discriminate among the different microtubules within the cell. One
potential mechanism to facilitate molecular heterogeneity of mi-
crotubules involves application of a variety of posttranslational
modifications (PTMs) to the exposed carboxyl-terminal tails of
tubulin (6, 7), such as detyrosination/tyrosination (8, 9), polyglycy-
lation (10, 11), and polyglutamylation (12). Brain tubulin is subject
to each of these PTMs. Thus, PTM of discrete subpopulations of
microtubules in the cell might serve as molecular ‘‘traffic signs’’ or
‘‘directional cues’’ for different molecular motors.
Enzymes that mediate PTM of tubulin carboxyl-terminal tails
include a unique family of proteins possessing a tubulin tyrosine
ligase (TTL) domain. The original TTL enzyme performs tyrosi-
nation of -tubulin (13, 14). Although a vital role of TTL in
neuronal organization has been discovered (15), a function of
tubulin tyrosination as amolecular traffic sign formolecularmotors
has not been demonstrated (15, 16). Recently related members of
the enzyme family called tubulin tyrosine ligase-like (TTLL) pro-
teins were identified (17). Mammals have at least a dozen loci
capable of encoding independent TTLL proteins (17, 18). Of these
proteins, at least two TTLLs can incorporate glutamate to tubulins.
TTLL1 is a catalytic subunit of -tubulin-preferring polyglutamy-
lase (17), whereas TTLL7 preferentially polyglutamylates-tubulin
(18). There is evidence to suggest that cellular activities, e.g., ciliary
and flagellar motility (19), neuronal differentiation (18), and cen-
triole stability (20), involve tubulin polyglutamylation. However,
despite identification of the enzymes and analysis of their function
in vitro (17, 18), an in vivo function for tubulin polyglutamylation in
mammals, especially in the brain, has remained unclear.
To test whether polyglutamylated -tubulin could function as a
molecular traffic sign for molecular motors, we analyzed ROSA22
mice (21) that lack functional PGs1, a component of -tubulin-
preferring polyglutamylase complex (22). Here we provide evi-
dence for a function of -tubulin polyglutamylation in vivo, to
regulate intracellular targeting of KIF1 kinesin motor and its cargo
synaptic vesicles in neurons and to modulate continuous synaptic
transmission.
Results
Tubulin Modification in ROSA22 Mice. PGs1, the protein encoded by
Gtrgeo22 (21), is a noncatalytic subunit of an enzyme complex with
polyglutamylase activity preferential to -tubulin (22). PGs1 is
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expressed in testis and in the nervous system [see supporting
information (SI) Fig. 7], where polyglutamylated tubulin is prom-
inent (23). PGs1 functions as a scaffold protein to localize a catalytic
subunit of polyglutamylase to tubulin ormicrotubules (SI Fig. 8). To
investigate functions for -tubulin polyglutamylation in vivo, we
analyzedROSA22mutantmice, which have amutation inGtrgeo22
(21) that results in a loss of native PGs1 (Fig. 1A). We first analyzed
the status of the PTM of tubulin extracted from brains of ROSA22
mutant mice byWestern blotting with GT335monoclonal antibody
(mAb) that recognizes both mono- and polyglutamylated tubulin
(23). ROSA22 mutants displayed a dramatic reduction in steady-
state level of polyglutamylated-tubulin (Fig. 1A and SI Fig. 9). No
difference was observed in the steady-state level of acetylated
-tubulin, whereas tyrosinated -tubulin was also decreased in
ROSA22 mutants (Fig. 1A and SI Fig. 9). Analysis by high-
resolution two-dimensional PAGE (Fig. 1B) verified that only
-tubulin was grossly affected by the loss of PGs1 function in
ROSA22 mutants. In ROSA22 mutants, the relatively acidic forms
of -tubulin found in wild-type mice were replaced with new, more
basic forms (Fig. 1B), suggesting a gross loss of the polyglutamate
side chain on -tubulin in brains of ROSA22 mutants. Consistent
with this interpretation,mass spectrometry ofmajor-tubulin spots
in Coomassie brilliant blue (CBB)-stained gel detected only mono-
glutamylated forms of-tubulin in brains ofROSA22mutants (Fig.
1 C and D and SI Table 1). We verified these findings by two-
dimensional PAGE/Western blot analyses, which demonstrated a
decrease in the numbers of polyglutamylated and tyrosinated
-tubulin species (Fig. 1E). This analysis also revealed an extremely
minor reduction of highly polyglutamylated species of -tubulin.
Thus, ROSA22 mice can be used to investigate the physiological
function of -tubulin polyglutamylation as a molecular traffic sign
for molecular motors in the nervous system in vivo.
Intracellular Distribution of Polyglutamylated Tubulin. If PTM of
tubulin regulates targeting of different molecular motors in vivo,
cells should display discrete subcellular distribution of microtubules
with different PTMs. To investigate the subcellular distribution of
polyglutamylated -tubulin in neurons, we cultured explanted
superior cervical ganglia (SCG) and dissected them into neurites
and cell bodies. Consistent with the prediction, polyglutamylated
-tubulin was enriched in neurites, whereas modified -tubulin was
concentrated in soma (Fig. 2A) (18). To investigate further the
subcellular distribution of polyglutamylated -tubulin, we per-
formed immunocytochemical staining of cultured hippocampal
neurons with B3 mAb. This antibody has been reported to react
with both polyglutamylated - and -tubulin derived from mouse
brain (19). Surprisingly, under the experimental conditions used, we
found that mAb B3 selectively recognized glutamylated -tubulin
(SI Fig. 10). Both axonal and dendritic processes contained poly-
glutamylated -tubulin (Fig. 2B). In vivo, polyglutamylated -
tubulinwas localized predominantly in process-rich regions, e.g., the
molecular layer of cerebellum (Fig. 2C). These findings support a
model for a function of polyglutamylated -tubulin as a molecular
traffic sign for targeting of certain motor proteins into these
structures.
Effects of -Tubulin Polyglutamylation on Binding of Motor Proteins
to Microtubules. The binding affinity of kinesin motors to micro-
tubules in vitro can be affected by the extent of tubulin polyglu-
tamylation (5, 24). To investigate whether -tubulin polyglutamy-
lation affects binding of kinesins to microtubules, we analyzed the
ability of kinesins to copurifywithmicrotubules isolated frombrains
of ROSA22 mutant and control mice (Fig. 3A). Because binding
affinities of structural microtubule-associated proteins (MAPs) can
also be affected differently by the extent of tubulin polyglutamy-
lation (25, 26), we also investigated the ability of MAPs to be
coprecipitated with microtubules. In the presence of ATP, which
promotes detachment of kinesin motors from microtubules, all
MAPs analyzed except MAP2 exhibited weaker binding affinity to
microtubules isolated from ROSA22 mutants (Fig. 3B). In the
presence of adenosine 5-[,-imido]triphosphate (AMP-PNP),
which inhibits detachment of kinesins from microtubules, KIF1A,
KIF5, dynein, and MAP1A displayed weaker binding to microtu-
bules isolated fromROSA22 homozygotes (Fig. 3B). No significant
difference in total steady-state levels of each MAP and motor
protein was observed between wild-type and ROSA22 mutant
Fig. 1. PTM of tubulin in ROSA22 mutant mice. (A) Representative Western
blot analysis of tubulins in brain lysates of adult wild-type (/) and ROSA22
homozygote (/) mice. Brain homogenate of ROSA22 homozygote (/)
mice lacked PGs1 and contained a significantly less amount of polyglutamy-
lated (PG-) and tyrosinated (Tyr-) tubulin than that of wild-type (/) mice.
The amounts of acetylated (Ac-), -, -, -tubulin, neurofilament H (NF-H),
actin, and GAPDH were not different between wild-type and ROSA22 ho-
mozygote. Quantitative analyses of signal intensities are shown in SI Fig. 9. (B
and C) Brain lysates from wild-type (/) and ROSA22 mutant (/) were
subjected to high-resolution two-dimensional electrophoresis. (B) The images
of CBB-stained two-dimensional gel were colorized and merged; green, wild-
type; red, mutant. (C) Major spots were numbered. (D) Mass spectrometry of
the -tubulin carboxyl terminus digested from major spots shown in the
illustration in C. (Left) Wild type (W). (Right) Mutant (M). The spot number
corresponds to the numbering in the illustration (e.g., W1 corresponds to the
sample 1 in the wild type). The peak detected in each spot was ordered
numerically, and the corresponding peptide mass and the deduced carboxyl-
terminal modifications are listed in SI Table 1. Formally, as indicated in the
table, the mass spectrometry cannot exclude the existence of relatively low
abundance of biglutamylated forms of 2 -tubulin (2  2E). (E) Western
blot analysis of high-resolution two-dimensional electrophoresis of tubulins
from brains of wild-type and homozygous ROSA22 mice. The blot was probed
in sequence with antibodies against polyglutamylated, -, -, acetylated, and
tyrosinated tubulin.
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brains (Fig. 3B). These results indicate that polyglutamylation of
-tubulin influences the in vitro binding properties of a broad range
of MAPs, but in particular, KIF1A, KIF5, cytosolic dynein, and
MAP1A. The results also raise the possibility that binding of those
MAPs to microtubules in vivo could be altered in neurons in
ROSA22 mice.
Abnormal KIF1 Distribution in PGs1-Deficient Neurons and Mice. To
investigate the role of -tubulin polyglutamylation in targeting
molecular motors to subcellular destinations, we analyzed the
distribution of kinesin motors in SCG explants cultured from
wild-type and ROSA22 mutant mice. The distribution of KIF1A
was altered in explants of SCG from ROSA22 mutant mice, with
KIF1A being reduced in neurites compared with controls (Fig. 4 A
and B). As an independent method to verify this finding, we
transfected hippocampal neurons isolated from wild-type and
ROSA22 mutant mice with green (GFP) or yellow (YFP) fluores-
cent protein-tagged KIF1A and KIF5A kinesins (Fig. 4C). A
GFP-KIF1A fusion protein entered neurites in cultured hippocam-
pal neurons from wild-type but not ROSA22 mutant mice (Fig.
4C). In contrast, a YFP-tagged KIF5A entered neurites in cells
from animals of both genotypes (Fig. 4C). In vivo, KIF1A was
present in regions enriched by polyglutamylated -tubulin, e.g., the
molecular layer of cerebellum (Figs. 2C and 4D). In ROSA22
mutants, immunoreactivity for KIF1A was greatly reduced in this
structure (Fig. 4D). The difference in the extent of reduction of
KIF1A in the molecular layer of the cerebellum compared with
neurites of explanted SCG could be the result of several factors,
including the different cell types (in vitro versus in vivo) and
analytical methods (Western blotting versus immunofluorescence).
However, in each case, the steady-state level of KIF1A is clearly
reduced in neuronal processes. Taken together, these results dem-
onstrate that in at least some populations of neurons, targeting of
KIF1A into neurites is influenced by -tubulin polyglutamylation.
Mislocalization of KIF1A Cargo, Synaptic Vesicles, in PGs1-Deficient
Mice. Impaired targeting ofKIF1A into neuronal processes in brains
of ROSA22 mutant mice should be associated with altered distri-
bution of KIF1A-dependent cargo, such as synaptic vesicles (1).
Indeed we observed a modest but significant decrease in density of
synaptic vesicles in the synaptic terminals of the hippocampal CA1
region in ROSA22 mutant mice compared with wild-type mice
(Fig. 5 A and B and SI Fig. 11). We also analyzed the steady-state
level of synaptic vesicle proteins in brains of wild-type andROSA22
mutant mice. Western blot analysis indicated no significant differ-
ence in levels of either synaptotagmin or synaptophysin (SI Fig. 12
A and B). In addition, N-cadherin, a cargo of KIF3A-containing
kinesin-2 motor (27), and amyloid precursor protein, a cargo of
KIF5-containing kinesin-1 motor (28), were each distributed sim-
ilarly in brains of wild-type andROSA22mutantmice (SI Fig. 12C).
Finally, another cargo of kinesin-1, mitochondria (4), was also
distributed in a similar manner in neurites in neurons from wild-
type and ROSA22 mutant mice (SI Fig. 12D). These results are
consistent with the selective impairment of KIF1A intracellular
distribution in ROSA22 mutant mice.
Impaired Synaptic Transmission in PGs1-Deficient Mice. Given the
reduced density of synaptic vesicles observed in ROSA22 mutant
mice, we examinedwhetherKIF1A-dependent electrophysiological
characteristics are affected in the brains of these animals. Consis-
tent with our findings, a field excitatory postsynaptic potential
(fEPSP) induced by a brief high-frequency stimulation (100 Hz, 19
stimuli) within CA3–CA1 synapse was more rapidly attenuated in
ROSA22 mutant animals compared with control littermates (Fig.
6A). The fEPSP slopes declined faster in brain slices fromROSA22
Fig. 2. Intracellular distribution of polyglutamylated tubulins. (A) SCG
explants from wild-type (/) and ROSA22 mutant (/) were surgically
dissected into soma (S) and neurites (N). To obtain equal amounts of tubulin,
soma samples contained 3-fold more protein than samples from neurites. The
samples were immunoblotted with antibodies specific for polyglutamylated
(PG-) or - or -tubulin. (B) Hippocampal neuronal cultures from wild-type
(/) or ROSA22 homozygote mice (/) were fixed and stained with mAb B3
that reacted selectively with PG--tubulin under the conditions used (SI Fig.
10) together with anti--tubulin (mAb, DM1A labeled with FITC) and poly-
clonal anti-MAP2 antibodies. Both axonal (arrowheads) and dendritic (arrows)
processes react with mAb B3. Red, PG--tubulin; green,-tubulin; cyan, MAP2.
(Scale bar, 30 m.) (C) Sagittal sections of brain from control (/) and
ROSA22 mutant (/) mice were stained with B3 or DM1A (green) and
TOTO-3 (magenta) to identify DNA. (Scale bar, 20 m.)
Fig. 3. Effects of -tubulin polyglutamylation on binding of MAPs to micro-
tubules. (A) Crude microtubules were prepared from brain homogenates of
wild-type (/) or ROSA22 mutant (/) in the presence of ATP or AMP-PNP.
Cosedimented kinesins and MAPs were detected by Western blot analysis. The
amount of protein applied was monitored by the intensity of the CBB-stained
tubulin. (B) Signal intensities were quantified and are represented as a per-
centage of mutant signal relative to wild-type signal. (Top) ATP-present
sample. NA, not applicable. (Middle) AMP-PNP-present sample. (Bottom)
Total brain homogenate (bottom). Open columns, wild type; filled columns,
mutant. *, P  0.05; **, P  0.01; ***, P  0.001, with paired t test.








mutants than in slices from wild-type controls (Fig. 6B), and the
fEPSP slopes halved significantly faster in ROSA22 homozygote
CA3–CA1 synapses (Fig. 6C). These data suggest that the docked
synaptic vesicles at the active zone are decreased in ROSA22 mice
as predicted from the result of EM analysis. In contrast, no
difference was observed in the ratio of paired-pulse facilitation, a
presynaptic form of short-term synaptic plasticity, between wild-
type and ROSA22 homozygotes (Fig. 6D), suggesting that the
molecular machinery of transmitter release is not impaired. To-
gether, these results support a model where -tubulin polyglutamy-
lation influences targeting of KIF1A into neurites that alters the
amount of docked synaptic vesicles in presynaptic sites, which in
turn modulates continuous synaptic transmission.
Discussion
We provide evidence for a role of posttranslational modification
(PTM) of -tubulin in regulating targeting of KIF1 kinesin into
neurites. The absence of functional PGs1 in ROSA22 mice results
in a dramatic reduction in poly-, but interestingly not monoglu-
tamylated, -tubulin within the mouse brain. In mouse brain,
-tubulin is polyglutamylated on Glu445 (29). Polyglutamylation of
Fig. 4. Altered distribution of KIF1 in ROSA22 mutant neurons and mice. (A) Equal amounts of soma (S) and neurite (N) lysates prepared from wild-type (/) and
ROSA22 mutant (/) mice were subjected to Western blot analyses, with antibodies against proteins indicated. (B) Signal intensities of bands of KIF1A, 3A, 5, and
GAPDH were quantified, and the data are presented as the ratio of the amount in neurites to that in soma. The values presented are mean SEM of three independent
experiments. **, P  0.01 with paired t test. (C) In wild-type (/) neurons, EGFP-KIF1A is localized in the soma (white arrow) and entered neurites (small white
arrowheads). In neurons from ROSA22 homozygotes (/), EGFP-KIF1A was present in the soma (white arrow) but was absent from neurites (white arrowheads). In
contrast, EYFP-KIF5A (white arrowheads) was able to enter neurites in neurons from both wild-type and ROSA22 homozygous mice. Green, kinesins; red, MAP2. (Scale
bar, 20m.) (D) Sagittal brain sections of control (/) and ROSA22 mutant (/) mice were stained with antibodies that recognize the proteins indicated (green) and
TOTO-3 (magenta). Note that the distribution of Tau and MAP1A appears to be altered in the ROSA22 mutant cerebellum. (Scale bar, 20 m.)
Fig. 5. Mislocalization of synaptic vesicles, cargoes of KIF1A, in ROSA22 mutant
mice. (A) Representative example of ultrastructure of the CA1 region of hip-
pocampus in wild-type (/) and ROSA22 mutant (/) mice. Synaptic vesicles
(arrowheads) and the postsynaptic side of the synaptic density (arrow) are indi-
cated. (Scale bar, 500 nm.) (B) The density of synaptic vesicles in synaptic terminals
was quantified from three independent mice of each genotype.
Fig. 6. Impaired synaptic transmission in ROSA22 mutant mice. (A) Hip-
pocampal slices were subjected to a brief high-frequency stimulation (100 Hz,
19 pulses). The fEPSP slopes during the entire high-frequency stimulation were
recorded from CA1 synapses of wild-type (/, black) and ROSA22 mutant
(/, red) mice. (B) Plot of fEPSP slope against stimulus no. (C) Stimulation no.
where fEPSP slopes halved are shown. The data represented are mean SEM
(n 8 for wild-type,/; n 9 for mutant,/). **, P 0.01 with Student’s
t test. (D) Paired-pulse facilitation (PPF) was quantified by using the ratios of
the second to the first fEPSP slopes at interpulse intervals of 50 ms.
3216  www.pnas.orgcgidoi10.1073pnas.0611547104 Ikegami et al.
tubulin presumably first requires ligation of glutamate through its
amide group to the -carboxyl side chain of Glu445 to generate
monoglutamylated -tubulin. Subsequently, additional glutamates
are added in a conventional manner through the -carboxyl group
of the monoglutamate to generate bi-, tri-, etc. polyglutamylated
-tubulin (29). Analysis of ROSA22 mutant mice indicates that
these activities are distinct; i.e., the polyglutamylase activity is
PGs1-dependent, whereas the monoglutamylase activity is PGs1-
independent. Thus, at least two discrete enzymatic activities are
capable of adding glutamate to -tubulin in the mouse brain.
As reported recently (18), the discrete distribution of polyglu-
tamylated -tubulin in neuronal cells is striking. Polyglutamylated
-tubulin appears to have a similar distribution within axons and
dendrites, which suggests that -tubulin polyglutamylation by itself
is unlikely to function as a molecular signpost to facilitate discrim-
ination between axonal and dendritic microtubules. One possibility
is that this modification could function as part of a combinatorial
code of tubulin modification that allows molecular machinery to
discriminate between these subcellular compartments. In hip-
pocampal neurons in culture, KIF1 is distributed evenly in both
axonal and dendritic processes (30), whereas KIF5 displays a highly
polarized, i.e., axon-preferential distribution (30, 31). Our results
indicate that -tubulin polyglutamylation positively influences
movement of a ‘‘nonpolar kinesin’’ KIF1 from soma into neurites.
However, this specific modification appears to have no direct
influence on the axon-selective distribution of a ‘‘polar kinesin’’
KIF5. Polarized targeting of kinesins such as KIF5 might be
regulated by other tubulin modifications, such as -tubulin poly-
glutamylation or monoglutamylation of either - or -tubulin.
A model can be proposed for a molecular mechanism as to why
the distribution of KIF1 is affected by loss of -tubulin polyglu-
tamylation whereas distributions of KIF3 and KIF5 appear unaf-
fected. The model is based on a unique molecular characteristic of
KIF1. KIF1 moves along microtubules by ‘‘biased Brownian move-
ment’’ (32) because it can function as amonomeric motor (4). KIF1
is attracted to the negatively charged -tubulin carboxyl terminus
while transiting a weak-binding state during biased Brownian
movement (33, 34). The long positively charged K loop present in
KIF1 (32) can interact strongly with the highly negatively charged
polyglutamate side chain on -tubulin (33). This ionic force may be
required to maintain interaction between monomeric forms of
KIF1A and microtubules in vivo. Thus, loss of -tubulin polyglu-
tamylation in ROSA22 mutants would impair KIF1–microtubule
interaction, when KIF1 is in the weak-binding state. In contrast,
KIF5–microtubule binding is mediated mainly by interaction be-
tween the short K loop ofKIF5 and theC terminus of-tubulin (35,
36). Unlike KIF1, KIF5 invariably functions as a dimer and has two
motor heads, which allows it to maintain attachment to microtu-
bules by onemotor headwhile the other head glides over the tubulin
surface. Consequently, movement of kinesins other than KIF1 may
be relatively insensitive to the loss of -tubulin polyglutamylation.
Under this model, other tubulin modifications, such as -tubulin
polyglutamylation, - and -tubulin monoglutamylation, and tubu-
lin acetylation, or combinations of such modifications, may affect
the trafficking of other kinesins. This model is consistent with a
recent report that acetylation of -tubulin, despite being located on
the inner lumen of microtubules, affects binding and transport of
kinesin-1 (37).
Our model predicts that changes in polyglutamylation of -tu-
bulin are the underlying cause of altered distribution of KIF1 and
modulated synaptic function in ROSA22 mice. However, it is
important to consider whether other mechanisms could be respon-
sible for these effects. ROSA22 mutant mice also displayed a
decrease in tyrosinated -tubulin. At present, the mechanism
underlying this additional change is unclear. During differentiation
of mouse neurons in culture, polyglutamylation and detyrosination
[to produce 2-tubulin (38)] of -tubulin display similar kinetics
(39), which raises the possibility that these posttranslational changes
may be coordinated, as has been observed for other PTMs of
tubulin (11). In the case of ROSA22 mutant mice, the reduction in
tyrosinated tubulin might be a consequence of the imbalance in
-tubulin polyglutamylation.
Could a reduction in tyrosinated -tubulin be responsible for
altered distribution of kinesins in ROSA22 mice? Conventional
kinesin can bind with greater affinity to detyrosinated tubulin than
to tyrosinated tubulin (40, 41). Given the reduced level of tyrosi-
nated tubulin in ROSA22mutant mice, kinesins might be expected
to bind more strongly to ROSA22 mutant-derived microtubules.
However, our results indicate that kinesins, including conventional
(KIF5) and monomeric (KIF1) kinesins, actually displayed weaker
binding affinity to ROSA22 mutant-derived microtubules than to
wild-type-derived microtubules. Although we cannot currently ex-
clude the possibility that the reduced level of tyrosinated tubulin
(or, the increased level of detyrosinated tubulin) contributes to
mislocalization of KIF1 and the defect of synaptic transmission we
observed in ROSA22 mutants, a mechanism for such an effect is
not immediately apparent. Lastly, it is also formally possible that
loss of function of PGs1 affects localization of KIF1 in amechanism
independent of the status of PTM of tubulin.
The loss of polyglutamylated -tubulin was associated with more
rapid attenuation of synaptic transmission. It is of interest that loss
of polyglutamylation of -tubulin produces a relatively subtle
mutant phenotype in mice. Our results indicate that the level of
KIF1A is reduced, but not absent, in at least a subset of neurites in
ROSA22mutantmice. Amore processive form of dimericUnc104/
KIF1A (42) can successfully enter neurites as can KIF5. Thus,
residual monoglutamylated -tubulin may facilitate targeting of
KIF1 into neurites with reduced efficiency. Alternatively, this
processmight occur in an-tubulin polyglutamylation-independent
manner. Finally, -tubulin polyglutamylation may be able to com-
pensate in part for loss of polyglutamylated -tubulin. The persis-
tence of reduced levels of KIF1A within some neurites would
explain why ROSA22 homozygotes do not display a lethal pheno-
type as found in KIF1A-deficient mice (43).
In conclusion, based on our findings we propose a model where
PTM of tubulin modulates synaptic transmission through proper
targeting of a kinesin motor to its destination. An interesting
question concerns whether alterations in the steady-state level of
PTM of tubulin might either be associated with, or contribute to,
development of common neuronal pathologies associated with
altered binding ofMAPs or synaptic function such as schizophrenia
or Alzheimer’s disease.
Materials and Methods
Mice.ROSA22mutantmicewere generated as described previously
(21). All experimentationwithmicewas conducted under protocols
approved by Institutional Animal Care and Use Committees of the
respective institutions.
Antibodies and Western Blot Analysis. Anti-PGs1 polyclonal anti-
body was raised in rabbits by using maltose-binding protein-fused
PGs1 as a substrate. Recombinant PGs1 was purified by amylose
resin (New England Biolabs, Ipswich, MA), mixed with Freund’s
adjuvant (Sigma–Aldrich, St. Louis, MO) and injected s.c. on the
dorsum of rabbits. Specificity of the antibody was confirmed by
Western blot analysis comparing protein from wild-type and RO-
SA22 mutant mice. GT335 mAb, which reacts with both glutamy-
lated forms of - and -tubulin (23), was a kind gift from B. Edde´
(CNRS, Montpellier, France). B3 mAb, which is reported to have
specificity for poly (bi)- glutamylated tubulins (19), was purchased
from Sigma–Aldrich (catalog no. T9822). For an unknown reason,
under the experimental conditions used, the specific lot (no.
022K4805) used in these studies reacted with glutamylated -tu-
bulin but not glutamylated-tubulin (SI Fig. 10). Information on all
other antibodies used and the method of Western blotting is
provided in SI Materials and Methods.








Two-Dimensional Electrophoresis. Tissues were homogenized in lysis
buffer (7 M urea/2 M thiourea/2% CHAPS/40 mM DTT/2% IPG
buffer, pH 3–10), and samples were subjected to isoelectric focusing
(IEF) in an immobilized pH linear gradient gel (IPG gel) of pH
4.5–5.5, 24 cm in length (Amersham, Piscataway, NJ). Second-
dimensional gel electrophoresis was performedby using laboratory-
cast SDS/polyacrylamide gels (12%). A detailed protocol for IEF
is provided in SI Materials and Methods.
Mass Spectrometry. Protein spots in gel were excised, rinsed in
acetonitrile, dehydrated, and reduced. After alkylation, the samples
were incubated overnight at 37°C in digestion buffer containing
endopeptidase Lys-C. Peptides were extracted and applied to a
MALDI plate, and 2,5-dihydroxybenzoic acid was applied to the
peptide to form cocrystals. Mass spectrometry was performed as
described (44, 45). A detailed protocol is available in SI Materials
and Methods.
Primary Culture. Hippocampal culture was prepared as described
previously (46) with the modifications listed in SI Materials and
Methods. Microexplants of mouse superior cervical ganglion were
prepared as described previously (47) and cultured on a poly-L-
lysine- and laminin-coated plastic dish.
Immunocytochemistry, Immunohistochemistry, and Electron Micros-
copy. These anatomical and morphological analyses were per-
formed by using modifications of standard methods. For detailed
information on specific methods, see SI Materials and Methods. To
determine the density of synaptic vesicles, 10 fields of view that each
contained at least 32 nerve terminals with postsynaptic density were
photographed randomly, and the numbers of synaptic vesicles in
each nerve terminal were counted. Three independent mice were
analyzed for each strain. Data represent mean  SD (n  151 for
wild type, n  136 for mutant). Statistical analysis was done with
one-way ANOVA.
Cosedimentation Assay of MAPs. Crude tubulin was prepared from
an adult mouse brain by one cycle of assembly-disassembly in
PIPESbuffer (100mMPIPES, pH6.8/1mMEGTA/1mMMgSO4)
containing amixture of protease inhibitors (10MPMSF/10g/ml
leupeptin). The brains were homogenized in the buffer and cen-
trifuged at 4°C (50,000 g for 30 min). Either 1 mMATP (pH 6.8)
or 1 mM AMP-PNP (pH 6.8) was added to the supernatant
containing 1mMGTPand 20%glycerol. The supernatant was then
incubated at 37°C for 35 min. After the incubation, 20 M Taxol
was added to the mixture. After centrifugation at 150,000  g for
40 min at 37°C, the pellet was boiled in SDS/PAGE sample buffer.
The amounts of tubulin in samples were determined by electro-
phoresis of the samples and staining of tubulins with CBB. Data
represent mean  SEM from five independent experiments. Sta-
tistical analysis was performed by using a paired t test.
Electrophysiology. Hippocampal slices were prepared essentially
as described (48) with modifications shown in SI Materials and
Methods.
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